to go to the previous page
Tuesday, November 3, 2009
Click the plus sign to see more detailed information
about each speaker.
, M.D., Ph.D., FRCP(C), Clinician-Scientist
, Ontario Cancer Institute and Princess Margaret Hospital
Dr. Bristow is currently a Clinician-Scientist at the Princess Margaret Hospital-University Health Network and Associate Professor in Radiation Oncology and Medical Biophysics at the University of Toronto. He is a Senior-Scientist at the Ontario Cancer Institute (Applied Molecular Oncology Division) and CORE I Director of the STTARR Cellular and Tissue Imaging Platform (www.sttarr.ca).
His primary research interests are in DNA damage responses and repair as relates to prostate cancer carcinogenesis and prostate cancer treatment response. His most recent work involves the roles of hypoxia, p53 and PML in DNA repair (Cancer Research-2008/Nature Reviews Cancer-2008; Cancer Research-2005; J Cell Biology-2007).
His has leadership roles in:
Co-Administrator, Canadian Prostate Cancer BioResearch Network (CPCRI-funded national molecular prostate cancer research network)
Chair, Scientific and Medical Advisory Board -Prostate Cancer Research Foundation of Canada.
Head, PMH Prostate Cancer Research Program
Twice a Canadian Foundation of Innovation Awardee
Editor, Basic Science of Oncology Textbook
He has served on grant panels for the CIHR, NCIC, CPCRI, PCRFC, NIH and US DOD Prostate and Breast programs.
He has over 120 published papers, abstracts and book chapters and has been an Invited international Speaker or Visiting Professor on more than 70 occasions. He was made a Canadian Cancer Society Research Scientist in 2004.
Lilie Lin, M.D., University of Pennsylvania
Audio Synchronized to PowerPoint